|
The following tables set forth the computation of basic and diluted earnings per share:
|
|
|
13 Weeks Ended
|
|
|
|
|
October 29, 2022
|
|
|
October 30, 2021
|
|
|
|
|
Net Income
|
|
|
|
|
|
|
Shares
|
|
|
Net Income
|
|
|
|
|
|
|
Shares
|
|
|
|
|
(millions, except per share data)
|
|
|
Net income and average number of
shares outstanding
|
|
$
|
108
|
|
|
|
|
|
|
|
271.0
|
|
|
$
|
239
|
|
|
|
|
|
|
|
305.8
|
|
|
Shares to be issued under deferred
compensation and other plans
|
|
|
|
|
|
|
|
|
|
|
1.0
|
|
|
|
|
|
|
|
|
|
|
|
1.1
|
|
|
|
|
$
|
108
|
|
|
|
|
|
|
|
272.0
|
|
|
$
|
239
|
|
|
|
|
|
|
|
306.9
|
|
|
Basic earnings per share
|
|
|
|
|
|
$
|
0.40
|
|
|
|
|
|
|
|
|
|
|
$
|
0.78
|
|
|
|
|
|
|
Effect of dilutive securities:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Stock options and restricted
stock units
|
|
|
|
|
|
|
|
|
|
|
5.7
|
|
|
|
|
|
|
|
|
|
|
|
6.9
|
|
|
|
|
$
|
108
|
|
|
|
|
|
|
|
277.7
|
|
|
$
|
239
|
|
|
|
|
|
|
|
313.8
|
|
|
Diluted earnings per share
|
|
|
|
|
|
$
|
0.39
|
|
|
|
|
|
|
|
|
|
|
$
|
0.76
|
|
|
|
|
|
|
|
|
39 Weeks Ended
|
|
|
|
|
October 29, 2022
|
|
|
October 30, 2021
|
|
|
|
|
Net Income
|
|
|
|
|
|
|
Shares
|
|
|
Net Income
|
|
|
|
|
|
|
Shares
|
|
|
|
|
(millions, except per share data)
|
|
|
|
|
Net income and average number of
shares outstanding
|
|
$
|
668
|
|
|
|
|
|
|
|
274.6
|
|
|
$
|
687
|
|
|
|
|
|
|
|
309.3
|
|
|
Shares to be issued under deferred
compensation and other plans
|
|
|
|
|
|
|
|
|
|
|
1.0
|
|
|
|
|
|
|
|
|
|
|
|
1.0
|
|
|
|
|
$
|
668
|
|
|
|
|
|
|
|
275.6
|
|
|
$
|
687
|
|
|
|
|
|
|
|
310.3
|
|
|
Basic earnings per share
|
|
|
|
|
|
$
|
2.43
|
|
|
|
|
|
|
|
|
|
|
$
|
2.21
|
|
|
|
|
|
|
Effect of dilutive securities:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Stock options and restricted
stock units
|
|
|
|
|
|
|
|
|
|
|
6.4
|
|
|
|
|
|
|
|
|
|
|
|
6.7
|
|
|
|
|
$
|
668
|
|
|
|
|
|
|
|
282.0
|
|
|
$
|
687
|
|
|
|
|
|
|
|
317.0
|
|
|
Diluted earnings per share
|
|
|
|
|
|
$
|
2.37
|
|
|
|
|
|
|
|
|
|
|
$
|
2.17
|
|
|
|
|
|
In addition to the stock options and restricted stock units reflected in the foregoing table, stock options to purchase 12.3 million and 14.3 million shares of common stock and restricted stock units relating to 0.8 million and 1.0 million shares of common stock were outstanding at October 29, 2022 and October 30, 2021, respectively, but were not included in the computation of diluted earnings per share because their inclusion would have been antidilutive or they were subject to performance conditions that had not been met.
|